Role of Canagliflozin in the Evolution of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus

被引：0
|
作者：
Tejera-Perez, Cristina
Sanchez-Bao, Ana
Soto-Gonzalez, Alfonso
Bellido-Guerrero, Diego
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1291-P
引用
收藏
页码：A346 / A346
页数：1
相关论文
共 50 条
  • [41] How Common Is Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease in Patients With Primary Biliary Cholangitis
    Ranginani, Dheeksha
    Williams, Elizabeth E.
    Mladenovic, Andrea
    Vuppalanchi, Raj K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1027 - S1029
  • [42] Increased plasma osteopontin levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
    Wang, Cong
    He, Miao
    Peng, Jiajia
    Li, Shengbing
    Long, Min
    Chen, Wenwen
    Liu, Dongfang
    Yang, Gangyi
    Zhang, Lili
    CYTOKINE, 2020, 125
  • [43] Prevalence of nonalcoholic fatty liver disease in type 2 diabetes mellitus patients from the Eastern region of India
    Sinha, Anirban
    Bankura, Biswabandhu
    DIABETES EPIDEMIOLOGY AND MANAGEMENT, 2023, 12
  • [44] Prevalence and risk factors of nonalcoholic fatty liver disease in a population of Chinese patients with type 2 diabetes mellitus
    Jing, Xu
    Ning, Bu
    Ting, Li
    Yang, Jiao
    Sha, Zhao
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2016, 32 (SUPP 2) : 49 - 49
  • [45] Association of glucagon-to-insulin ratio and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
    Moh, Myint Aung Moh
    Jung, Chan-Hee
    Lee, Bora
    Choi, Dughyun
    Kim, Bo-Yeon
    Kim, Chul-Hee
    Kang, Sung-Koo
    Mok, Ji-Oh
    DIABETES & VASCULAR DISEASE RESEARCH, 2019, 16 (02): : 186 - 195
  • [46] Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
    Wu, Haiya
    Jia, Weiping
    Bao, Yuqian
    Lu, Junxi
    Zhu, Jiehua
    Wang, Ren
    Chen, Yaqing
    Xiang, Kunsan
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 (02) : 185 - 190
  • [47] Dapagliflozin Therapy Curative Effect Observation on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
    Hu, Chen Liang
    Wang, Yu Chuan
    Xi, Yu
    Yao, Xin Ming
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 82 : 122 - 129
  • [48] Nonalcoholic Fatty Liver Disease and Endothelial Dysfunction in Patients With Type 2 Diabetes
    Shin, Jang Yel
    Lim, Jung Soo
    Lee, Mi Young
    Chung, Choon Hee
    DIABETES, 2013, 62 : A119 - A119
  • [49] Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes and Chronic Kidney Disease
    Adrian, Therese
    Hornum, Mads
    Knop, Filip Krag
    Almdal, Thomas
    Rossing, Peter
    Lida, Lisa
    Heinrich, Niels Sondergaard
    Boer, Vincent Oltman
    Marsman, Anouk
    Petersen, Esben Thade
    Siebner, Hartwig Roman
    Feldt-Rasmussen, Bo
    NEPHRON, 2023, 147 (06) : 317 - 328
  • [50] Dapagliflozin Therapy in Type 2 Diabetes Patients with nonalcoholic Fatty Liver Disease
    Kahl, S.
    DIABETOLOGE, 2018, 14 (07): : 506 - 508
12345